Sweden's Qlucore Q4 net sales fall 44% amid competition
Sweden's Qlucore Q4 net sales fall 44% amid competition
Overview
Sweden AI diagnostics software firm's Q4 net sales fell 44% yr/yr amid competition, spending cuts
Adjusted EBITDA loss widened and net result remained negative in Q4
Company launched AI-based tests for Acute Myeloid Leukemia and Bladder Cancer
Outlook
Company expects full impact of cost reductions to be visible in August 2026
Qlucore says liquidity will be strengthened after EU project payment
Company notes continued cautious purchasing behavior and negative impact from US research funding cuts
Result Drivers
SALES DECLINE DRIVERS - Co said lower sales were due to increased competition from open-source solutions, customer cost-saving, and prioritization of diagnostics development
COST REDUCTIONS - Qlucore implemented further cost reductions, including staff reductions and a review of the sales process
MACRO HEADWINDS - Weaker global economy and cuts in American research funding negatively affected operations
Company press release: ID:nMFN6fM6kK
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| SEK 1.94 mln |
|
Q4 EPS |
| -SEK 0.08 |
|
Q4 Net Income |
| -SEK 3.38 mln |
|
Q4 Adjusted Free Cash Flow |
| -SEK 7.04 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)